Cargando…
A week seems to be weak: tailoring duration of antibiotic treatment in Gram-negative ventilator-associated pneumonia
The optimal length of antimicrobial therapy has not been extensively studied for a great majority of infections and, in critically ill patients affected by ventilator-associated pneumonia, is a persisting and unsolved issue confronting clinicians. The integration of biomarkers, clinical judgment, an...
Autores principales: | Martin-Loeches, Ignacio, Torres, Antoni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057223/ https://www.ncbi.nlm.nih.gov/pubmed/23336300 http://dx.doi.org/10.1186/cc11899 |
Ejemplares similares
-
Invasive Pulmonary Aspergillosis in Ventilator-associated Pneumonia:
The Hidden Enemy?
por: Torres, Antoni, et al.
Publicado: (2020) -
Evaluating antibiotic therapy for ventilator-associated pneumonia caused by gram-negative bacilli
por: Malhotra, Raj, et al.
Publicado: (2023) -
Is ventilated hospital-acquired pneumonia a worse entity than ventilator-associated pneumonia?
por: Vallecoccia, Maria Sole, et al.
Publicado: (2020) -
New antibiotics for Gram-negative pneumonia
por: Bassetti, Matteo, et al.
Publicado: (2022) -
Ventilator-associated tracheobronchitis: where are we
now?
por: Nseir, Saad, et al.
Publicado: (2014)